The chemical class known as SPATA5L1 activators encompasses a diverse range of compounds designed to modulate the activity of the SPATA5L1 protein, which is part of the AAA ATPase family. These activators are distinct molecules that can bind to the protein and influence its ATPase activity, which is central to its role in various cellular processes. The activation of SPATA5L1 by these chemicals can lead to an increase in its normal physiological functions. This can include enhancing the protein's ability to assist in the refolding of misfolded proteins, participating more actively in the degradation of proteins marked for proteolysis, and playing a more prominent role in the maintenance of mitochondrial integrity. The chemicals can interact with SPATA5L1 directly or indirectly by altering the cellular environment in a way that necessitates an upregulation of SPATA5L1 activity.
Within the cell, SPATA5L1 is integral to a balanced functioning of cellular mechanisms, and its activators are therefore crucial to maintaining this equilibrium. These activators can also play a role in modulating the activity of SPATA5L1 in response to cellular stress, such as DNA damage or the accumulation of misfolded proteins. By ensuring the proper function of SPATA5L1, they assist in the stabilization of intracellular processes, including but not limited to DNA repair, protein quality control, and organelle biogenesis. The chemical activators of SPATA5L1 are instrumental in aiding the protein to fulfill its role in these vital cellular operations, underpinning the protein's contribution to the overall cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
By inhibiting proteasomal degradation, this compound could lead to an accumulation of misfolded proteins, which may necessitate the activation of SPATA5L1 for protein quality control. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
An Hsp90 inhibitor that disrupts protein folding, which could increase demand for SPATA5L1-mediated protein quality control. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
By inhibiting calcineurin, this compound could alter signaling pathways and could possibly activate SPATA5L1. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $94.00 $355.00 | 46 | |
This compound disrupts mitochondrial membrane potential, which could increase the need for SPATA5L1 to maintain organelle integrity. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
As a topoisomerase inhibitor, camptothecin could possibly activate SPATA5L1 by inducing DNA damage and increasing the demand for AAA ATPases in DNA repair processes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
This compound induces DNA crosslinks and could possibly activate SPATA5L1 by requiring enhanced AAA ATPase activity for DNA repair. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
This NEDD8-activating enzyme inhibitor could affect protein turnover and could possibly activate SPATA5L1 for protein management. | ||||||